Advance your academic career, collaborate globally, and expand your network— join now !

Paul Witting

Prof. Dr. Paul Witting

Discipline of Pathology, Faculty of Medicine and Health, Charles Perkins Centre,...

Share Link

Share

Information

Professor Paul Witting is a research academic working in the Discipline of Pathology, Charles Perkins Centre, University of Sydney (USyd). Paul completed his PhD in Chemistry in 1994 and then worked as a postdoctoral researcher together with Professor Roland Stocker at the Heart Research Institute (1994–1999). He was awarded a Heart Foundation Travel Fellowship (2000–2002) that funded a second postdoctoral position at the University of British Columbia (Vancouver, Canada). On returning to Australia, he relocated, together with Professor Stocker, to the University of New South Wales, where he gained a nationally competitive ARC Fellowship (2003–2007) and continued as a senior postdoctoral researcher at the ANZAC Research Institute (Concord Hospital, Sydney). He joined the Discipline of Pathology at the University of Sydney in 2008 and established the Redox Biology group. The primary research focus for the Redox Biology group is to understand pathways for acute tissue insult (including myocardial infarct, stroke, kidney injury and inflammatory bowel disease) and, more broadly, vascular biology. The main goals of the research are to define the underlying mechanisms of acute injury to tissues and design and test specific inhibitors of oxidative damage and inflammation that may be central to the developing pathology.

Research Keywords & Expertise

Nitric Oxide
Oxidative Stress
Vascular Biology
Redox biology
Redox Mechanisms

Fingerprints

22%
Oxidative Stress
10%
Nitric Oxide
5%
Inflammatory Bowel Disease (IBD)
5%
Redox Mechanisms

Short Biography

Professor Paul Witting is a research academic working in the Discipline of Pathology, Charles Perkins Centre, University of Sydney (USyd). Paul completed his PhD in Chemistry in 1994 and then worked as a postdoctoral researcher together with Professor Roland Stocker at the Heart Research Institute (1994–1999). He was awarded a Heart Foundation Travel Fellowship (2000–2002) that funded a second postdoctoral position at the University of British Columbia (Vancouver, Canada). On returning to Australia, he relocated, together with Professor Stocker, to the University of New South Wales, where he gained a nationally competitive ARC Fellowship (2003–2007) and continued as a senior postdoctoral researcher at the ANZAC Research Institute (Concord Hospital, Sydney). He joined the Discipline of Pathology at the University of Sydney in 2008 and established the Redox Biology group. The primary research focus for the Redox Biology group is to understand pathways for acute tissue insult (including myocardial infarct, stroke, kidney injury and inflammatory bowel disease) and, more broadly, vascular biology. The main goals of the research are to define the underlying mechanisms of acute injury to tissues and design and test specific inhibitors of oxidative damage and inflammation that may be central to the developing pathology.